_edited_edit.jpg)
In answer to Coronavirus pandemic,
ISOP ISRAEL is currently working to switch some of its workshops to webinars
STAY CONNECTED
We will start in Q4 -2020
ISOP ISRAEL is proud to offer an inspiring program of 4 to 6 hours workshops, which will be held in Hebrew, by top-notch experts who will share their experience with you.
Based on the same concept that our symposium, the seminars will be multidisciplinary, and solution-oriented.
OUR OBJECTIVE:
To share proven methods and tools that you could apply in your environment.
POSTPONED
Sheba Medical Center
Machon Autoimmunity
_edited.jpg)
New Strategies for a Safer Use of Anticoagulants
Chair :
POSTPONED
Ariel University
Adelson Faculty of Medicine
.jpg)
Motherisk International Inaugural Workshop Treating the Mother,
Protecting the Unborn and the Newborn
Chair :
MD, FRCPC, FACMT,
Head, Pharmacology
Head of Institute of Clinical Pharmacology and Toxicology. Sheba Medical Centre
1-Tools and methods
- IHI Trigger tool to detect Adverse Drug Reactions in electronic Medical Records
-ISMPâMedication Safety Self-assessment for antithrombotic therapy
- Risk Communication to patient : BeMedwise
Adelson Faculty of Medicine, Ariel University
and Motherisk Israel Program, Shamir Hospital
Speakers :
to be confirmed
Prof Asher Ornoy
Prof Ilan Matok
Rana Cohen MSc
Prof Mati Berkovitch,
Dr Gali Pariente
Dr Shirin Namouz
Prof. Orna Citrin
Prof Didi Bentur
Mgr Maya Berlin
Chagit Klieger
Dr Yael Grin
2 -Experience sharing: Initiatives that work
- Sheba Medical Center
- Maayanei HaYeshua Medical Center
September 2020
Hadassah Medical Center
Jerusalem
December 2020
Pharma Company (tbc)
Tel Aviv region
_edited.jpg)
Polypharmacy
Deprescribing is an urgency!
Highlight on elderly patients
Chair :
Internist and Clinical Pharmacologist. Head of the Department of Medicine at the Hadassah University Hospital, Mt Scopus Campus, Jerusalem.
-
What is the extent of the issue?
-
The clever use of drugs in elderly people
-
Review of the tools for assessing polypharmacy: BEERS, STOP & START, Medication Appropriateness Index …
-
Who must be involved in the multidisciplinary approach? All stakeholders : any prescriber, the pharmacists and clinical pharmacists, the pharmacologists, the patients, the Ministry of Health, the Kupot Holim , the Industry and the Academy.
-
How to be involved ? : review of current initiatives
-
Review of the current tools, including the potential or current Artificial Intelligence solutions.
What the guidelines are telling us? do we need new guidelines?
November 2020 Sheba Medical Center
Machon Autoimmunity
.jpg)
Bio-pharmaceuticals, Biosimilars:
Israel and International Standards
Chair :
Head of Institute of Clinical Pharmacology and Toxicology. Sheba Medical Centre
Program under construction
ISOP ISRAEL is considering to organise its
2nd full-day symposium on this topic.
WORKSHOPS AUDIENCE
-
Clinician physicians, hospital &community, especially geriatrics, obstetricians, gynecologists, cardiologists, general practitioners, clinical pharmacologists
-
Pharmacists, Clinical Pharmacists, hospital &community
-
Risk managers, patient safety staff, quality of care staff
-
Nurses
-
Kupot Holim
-
Industry: Pharmacovigilance, marketing, regulatory affairs, medical affairs
-
Academy: Public Health, pharmacology, school of Pharmacy, school of Medicine, nurses ‘school, geriatrics, family physicians
-
Ministry of Health: Pharmacovigilance, risk management, quality of care, patient safety, geriatrics
